Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
ABMD
Abiomed Inc
ABMD
|
$296M |
| 2 |
Illumina
ILMN
|
$294M |
| 3 |
Trade Desk
TTD
|
$281M |
| 4 |
Axon Enterprise
AXON
|
$248M |
| 5 |
Broadridge
BR
|
$244M |
Top Sells
| 1 |
Verisk Analytics
VRSK
|
$512M |
| 2 |
FRC
First Republic Bank
FRC
|
$323M |
| 3 |
Baidu
BIDU
|
$312M |
| 4 |
ICICI Bank
IBN
|
$234M |
| 5 |
Stellantis
STLA
|
$200M |
Sector Composition
| 1 | Consumer Discretionary | 32.32% |
| 2 | Healthcare | 17.27% |
| 3 | Communication Services | 16.52% |
| 4 | Financials | 10.83% |
| 5 | Technology | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRUB
26
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $783M | 0.83% | 10,040,807 +865,569 | +9% | +$67.5M |
|
27
Microsoft
MSFT
$3.77T
| $776M | 0.82% | 5,795,828 -32,152 | -0.6% | -$4.31M |
|
28
DexCom
DXCM
$29.5B
| $725M | 0.77% | 4,835,289 -84,435 | -2% | -$12.7M |
|
29
Thermo Fisher Scientific
TMO
$186B
| $692M | 0.73% | 2,355,179 -3,215 | -0.1% | -$944K |
|
30
APA Corp
APA
$8.31B
| $686M | 0.73% | 23,688,967 -186,830 | -0.8% | -$5.41M |
|
31
Martin Marietta Materials
MLM
$37.2B
| $662M | 0.7% | 2,876,225 +1,940 | +0.1% | +$446K |
|
32
Arthur J. Gallagher & Co
AJG
$77.6B
| $629M | 0.67% | 7,182,325 -12,080 | -0.2% | -$1.06M |
|
33
Markel Group
MKL
$24.8B
| $621M | 0.66% | 570,019 +18,170 | +3% | +$19.8M |
|
34
Kirby Corp
KEX
$5.42B
| $607M | 0.64% | 7,679,245 -33,008 | -0.4% | -$2.61M |
|
35
ResMed
RMD
$40.2B
| $589M | 0.62% | 4,824,334 +26,553 | +0.6% | +$3.24M |
|
36
Wayfair
W
$9.67B
| $583M | 0.62% | 3,992,065 +497,644 | +14% | +$72.7M |
|
|
ABMD
37
DELISTED
Abiomed Inc
ABMD
| $578M | 0.61% | 2,219,136 +1,137,705 | +105% | +$296M |
|
38
LendingTree
TREE
$925M
| $576M | 0.61% | 1,371,614 -9,800 | -0.7% | -$4.12M |
|
|
39
Trade Desk
TTD
$26.7B
| $574M | 0.61% | 2,518,927 +1,231,808 | +96% | +$281M |
|
40
Royal Caribbean
RCL
$98.7B
| $562M | 0.6% | 4,636,301 -20,345 | -0.4% | -$2.47M |
|
41
NovoCure
NVCR
$1.38B
| $558M | 0.59% | 8,829,449 +789,924 | +10% | +$49.9M |
|
42
Service Corp International
SCI
$11.1B
| $554M | 0.59% | 11,838,754 -21,069 | -0.2% | -$986K |
|
|
43
ICICI Bank
IBN
$113B
| $547M | 0.58% | 43,415,637 -18,582,083 | -30% | -$234M |
|
44
Ionis Pharmaceuticals
IONS
$6.79B
| $543M | 0.58% | 8,444,249 -200,102 | -2% | -$12.9M |
|
45
Waters Corp
WAT
$18B
| $539M | 0.57% | 2,503,393 +2,416 | +0.1% | +$520K |
|
|
BLUE
46
DELISTED
bluebird bio
BLUE
| $537M | 0.57% | 4,223,534 -255,567 | -6% | -$32.5M |
|
47
Zillow
Z
$20.4B
| $536M | 0.57% | 11,564,525 +128,756 | +1% | +$5.97M |
|
48
NetEase
NTES
$86.2B
| $530M | 0.56% | 2,073,331 -33,791 | -2% | -$8.64M |
|
49
Mettler-Toledo International
MTD
$26.8B
| $530M | 0.56% | 631,283 -1,858 | -0.3% | -$1.56M |
|
|
50
Stellantis
STLA
$27.8B
| $515M | 0.55% | 36,876,440 -14,283,358 | -28% | -$200M |
|